Operating Lease, Right-of-Use Asset of Cue Biopharma, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cue Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Cue Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,602,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cue Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,602,000 +$568,000 +14% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,118,000 +$308,000 +6.4% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $3,589,000 -$1,984,000 -36% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $4,370,000 -$1,953,000 -31% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $4,034,000 -$3,026,000 -43% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $4,810,000 -$2,976,000 -38% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,573,000 -$2,927,000 -34% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,323,000 -$2,880,000 -31% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $7,060,000 -$2,501,000 -26% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $7,786,000 -$2,113,000 -21% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $8,500,000 -$1,384,000 -14% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $9,203,000 -$606,876 -6.2% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $9,561,000 +$6,192,000 +184% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $9,899,000 +$5,377,000 +119% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $9,884,000 +$4,228,000 +75% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $9,809,876 +$3,035,647 +45% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 $3,369,000 -$4,507,000 -57% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $4,522,000 -$3,628,000 -45% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $5,656,000 +$1,317,000 +30% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $6,774,229 +$1,437,203 +27% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $7,876,000 +$1,220,000 +18% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $8,150,000 +$471,000 +6.1% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $4,339,000 -$4,352,000 -50% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $5,337,026 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $6,656,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $7,679,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $8,691,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.